Site Search

Search
Showing 1 - 10 of 22 results
About the CF Foundation | CFTR Modulators | Genetic Therapies
New Cystic Fibrosis Drug Brings Gift of a Future, NPR Reports Online
News |
| 1 min read
About the CF Foundation | CFTR Modulators | Genetic Therapies
New Hope of Kalydeco (VX-770) Makes Headlines and Newscasts Around the Nation
News |
| 2 min read
About the CF Foundation | CFTR Modulators | Genetic Therapies
Foundation Makes Milestone Payment to Collaborator for Potential Dual-Acting Compound
News |
| 1 min read
About the CF Foundation | Genetic Therapies | CFTR Modulators
Foundation Showcased in BusinessWeek
News |
| 1 min read
About the CF Foundation | CFTR Modulators | Genetic Therapies
Promising Data For CF Drug Published in The Lancet
News |
| 1 min read
About the CF Foundation | Genetic Therapies | Research
Science Magazine Spotlights 20 Years of CF Research
News |
| 1 min read
About the CF Foundation | CFTR Modulators | Genetic Therapies
Foundation Makes Milestone Payment to EPIX Pharmaceuticals
News |
| 1 min read
About the CF Foundation | CFTR Modulators | Genetic Therapies
The New York Times and Other Major Media Outlets Feature Results of VX-770 Trial
News |
| 2 min read
About the CF Foundation | CFTR Modulators | Genetic Therapies
Wall Street Journal Health Blog: CF Foundation Not Just a Cheerleader
News |
| 2 min read
About the CF Foundation | CFTR Modulators | Genetic Therapies
Cystic Fibrosis Foundation Therapeutics Announces $15 Million Research Project for Development of Novel CF Treatment

Cystic Fibrosis Foundation Therapeutics Inc., the nonprofit affiliate of the Cystic Fibrosis Foundation, announced today a $15 million research agreement with biopharmaceutical company Shire plc to support the development of a new cystic fibrosis treatment targeting the underlying cause of the disease.

News |
| 2 min read